Tg Therapeutics (TGTX) Gross Margin (2021 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Gross Margin of 83.65% in Q1 2026, up 4.31% quarter-over-quarter from 80.19% in Q4 2025, and down 349.0% on a YoY basis from 33.59% in Q1 2025.
Tg Therapeutics (TGTX) Gross Margin (2021 - 2026) Analysis & Trends
Tg Therapeutics' Gross Margin history runs 6 years deep, the most recent figure standing at 83.65% for Q1 2026.
- In Q1 2026, Gross Margin fell 349.0% year-over-year to 83.65%; the TTM figure through Mar 2026 stood at 83.05% (down 437.0% YoY), while the FY2025 annual figure was 83.66%, down 464.0% from the prior year.
- Gross Margin was 83.65% for Q1 2026 at Tg Therapeutics, up from 80.19% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 97.88% in Q3 2023 to a low of 80.19% in Q4 2025.
- Historically, Gross Margin has averaged 88.41% across 5 years, with a median of 88.11% in 2023.
- The sharpest annual moves came in 2023 and 2024: Gross Margin slumped 1411 bps in 2023, then surged 363 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 96.25% in 2022, then slipped by 15 bps to 82.14% in 2023, then gained by 4 bps to 85.77% in 2024, then dropped by 6 bps to 80.19% in 2025, then increased by 4 bps to 83.65% in 2026.
- The last three Gross Margin figures came in at 83.65% (Q1 2026), 80.19% (Q4 2025), and 82.63% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 83.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.65% |
| Dec 31, 2025 | 80.19% |
| Sep 30, 2025 | 82.63% |
| Jun 30, 2025 | 86.58% |
| Mar 31, 2025 | 87.14% |
| Dec 31, 2024 | 85.77% |
| Sep 30, 2024 | 88.86% |
| Jun 30, 2024 | 88.70% |
| Mar 31, 2024 | 91.43% |
| Dec 31, 2023 | 82.14% |
| Sep 30, 2023 | 97.88% |
| Jun 30, 2023 | 88.11% |
| Mar 31, 2023 | 89.02% |
| Dec 31, 2022 | 96.25% |
| Sep 30, 2022 | 97.87% |
| Mar 31, 2021 | 82.47% |